Original document(8 pages)  中文版
    The present invention discloses a nitrogen gas pre-cooling throttle tumor ultra-low temperature therapeutic system. Said system adopts liquid nitrogen to pre-cool nitrogen gas, and its characterized by that after the normal-temperalure high-pressure nitrogen gas is introduced into the nitrogen gas injection electromagnetic valve, said nitrogen gas can be divided into two branches, on branch can be fed into interior liquid nitrogen Dewar vacuum vessel to lead out liquid nitrogen and make it be fed into pre-cooling heat exchanger to pre-cool the nitrogen gas; another branch can be passed through microparticle and aqueous vapor filter, then also divided into two branches, one branch can be pre-cooled by liquid nitrogen in pre-cooling heat exchanger, then inputted into frozen probe and further throttled and cooled; another branch can be heated by heating heat exchanger, then inputted into the frozen probe to heat the therapeutic region. Said invention can be extensively used in urological department, tumor department, department of dermatology, department of gynecology, chest surgery and others.
Application Number
申请号
200510029862 Application Date
申请日
2005.09.22
Title 名称 Nitrogen precooled throttling tumour ultra low temperature therapeutical system
Publication Number
公开号
1935096 Publication Date
公开日
2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61B18/02;A61F7/00
Applicant(s) Name
申请人
Shanghai Daoxiang Medical System Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 dingji tie
More information 更  多  信  息


 Related patents information
Cryosurgical instrument with vent holes and method using
Blood vessel support with coating to prevent blood vessel from becoming strictured again
Nitrogen precooled throttling tumour ultra low temperature therapeutical system
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.